William Mack & Associates
CVS icon

William Mack & Associates’s CVS Health CVS Stock Holding History

William Mack & Associates’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$45.7K Buy
+533
New +$52.2K 0.01% 253

Other funds holding CVS

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Capital World Investors
Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $187B AUM 13.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $704B AUM 26.74% 1-Year Est. Return

William Mack & Associates's CVS Position: Q3 2026 in Review

William Mack & Associates opened a new position in CVS Health (CVS) in Q3 2026: 533 shares worth $45.7K. The stake represents 0.01% of the portfolio and ranks #253 among its holdings.

1,724 funds tracked by Wall St. Rank hold CVS as of Q3 2026.

  • William Mack & Associates held 533 shares of CVS Health worth $45.7K as of Q3 2026.
  • CVS Health was a new William Mack & Associates position in Q3 2026.
  • CVS Health made up 0.01% of William Mack & Associates's portfolio in Q3 2026, its #253 holding.
  • 1,724 funds tracked by Wall St. Rank held CVS Health as of Q3 2026.

Based on William Mack & Associates's 13F filing for Q3 2026, filed 27 Oct 2026.